Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
BMC Palliative Care
|
March 19, 2013
Early evaluation predicts pain relief of irradiated bone metastases: a single-center prospective study
Pierre Truntzer, David Atlani, Marius Pop, et al.
International Journal of Colorectal Disease
|
October 16, 2013
Age impacts the pattern of care for elderly patients with rectal cancer
Florence Guillerme, Jean Baptiste Clavier, Hélène Nehme-Schuster, et al.
Cancers
|
November 9, 2013
Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy
Ludovic T Nguyen, Socheat Touch, Hélène Nehme-Schuster, et al.
Radiation Oncology (London, England)
|
April 21, 2022
Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis
Irfane Issoufaly, Claire Petit, Sébastien Guihard, et al.
BMC Cancer
|
December 16, 2022
Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort
Marie Bruand, Julia Salleron, Sébastien Guihard, et al.
Anticancer Research
|
June 10, 2019
Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted Therapies
Ziad El Ali, Sylvie Rottey, Philippe Barthelemy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 3, 2018
Practical contouring guidelines with an MR-based atlas of brainstem structures involved in radiation-induced nausea and vomiting
Arnaud Beddok, Jean-Christophe Faivre, Alexandre Coutte, et al.
Lancet (London, England)
|
March 7, 2026
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial
Sofia Rivera, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 17, 2025
Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial
Thomas Brion, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
Journal of Neuro-Oncology
|
June 5, 2012
Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy
Georges Noel, Aymeri Huchet, Loic Feuvret, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
BMC Palliative Care
|
March 19, 2013
Early evaluation predicts pain relief of irradiated bone metastases: a single-center prospective study
Pierre Truntzer, David Atlani, Marius Pop, et al.
International Journal of Colorectal Disease
|
October 16, 2013
Age impacts the pattern of care for elderly patients with rectal cancer
Florence Guillerme, Jean Baptiste Clavier, Hélène Nehme-Schuster, et al.
Cancers
|
November 9, 2013
Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy
Ludovic T Nguyen, Socheat Touch, Hélène Nehme-Schuster, et al.
Radiation Oncology (London, England)
|
April 21, 2022
Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis
Irfane Issoufaly, Claire Petit, Sébastien Guihard, et al.
BMC Cancer
|
December 16, 2022
Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort
Marie Bruand, Julia Salleron, Sébastien Guihard, et al.
Anticancer Research
|
June 10, 2019
Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted Therapies
Ziad El Ali, Sylvie Rottey, Philippe Barthelemy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 3, 2018
Practical contouring guidelines with an MR-based atlas of brainstem structures involved in radiation-induced nausea and vomiting
Arnaud Beddok, Jean-Christophe Faivre, Alexandre Coutte, et al.
Lancet (London, England)
|
March 7, 2026
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial
Sofia Rivera, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 17, 2025
Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial
Thomas Brion, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
Journal of Neuro-Oncology
|
June 5, 2012
Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy
Georges Noel, Aymeri Huchet, Loic Feuvret, et al.
Page
of 2